PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(12 sites)

United States

Children's Hospital Colorado, Aurora, Colorado

Children's National Medical Center, Washington D.C., District of Columbia

Nicklaus Children's Hospital, Miami, Florida

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois

Dana-Farber Cancer Institute, Boston, Massachusetts

St. Louis Children's Hospital, St Louis, Missouri

Duke Cancer Center, Durham, North Carolina

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Nationwide Children's Hospital, Columbus, Ohio

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Texas Children's Hospital, Houston, Texas

Seattle Children's Hospital, Seattle, Washington